We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSI icon
1576
Invesco Semiconductors ETF
PSI
$2.48B
$550K 0.01%
21,321
+21,066
+8,261% +$547K
ATNI icon
1577
ATN International
ATNI
$481M
$549K 0.01%
10,956
+9,176
+516% +$524K
MCRI icon
1578
Monarch Casino & Resort
MCRI
$2.19B
$549K 0.01%
12,303
+10,185
+481% +$417K
NVTA
1579
DELISTED
Invitae Corporation
NVTA
$549K 0.01%
12,658
+3,744
+42% +$128K
CBT icon
1580
Cabot Corp
CBT
$4.49B
$548K 0.01%
15,213
+439
+3% +$16.7K
BPMC
1581
DELISTED
Blueprint Medicines
BPMC
$547K 0.01%
5,909
-588
-9% -$45.3K
EVER icon
1582
EverQuote
EVER
$884M
$547K 0.01%
14,156
+12,449
+729% +$561K
MTB icon
1583
M&T Bank
MTB
$36.4B
$547K 0.01%
5,942
+760
+15% +$77.7K
RIGL icon
1584
Rigel Pharmaceuticals
RIGL
$785M
$547K 0.01%
22,782
+19,158
+529% +$470K
SPYX icon
1585
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.86B
$547K 0.01%
+19,644
New +$538K
CRUS icon
1586
Cirrus Logic
CRUS
$6.11B
$545K 0.01%
8,074
-4,708
-37% -$295K
IDGT icon
1587
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$523M
$545K 0.01%
11,683
-1,831
-14% -$92.9K
INO icon
1588
Inovio Pharmaceuticals
INO
$79.1M
$545K 0.01%
3,915
+2,044
+109% +$426K
CBAY
1589
DELISTED
Cymabay Therapeutics
CBAY
$545K 0.01%
75,209
+60,354
+406% +$323K
IRWD icon
1590
Ironwood Pharmaceuticals
IRWD
$711M
$544K 0.01%
60,463
+22,237
+58% +$221K
ALLE icon
1591
Allegion
ALLE
$14.3B
$543K 0.01%
5,485
-192
-3% -$19.5K
EBF icon
1592
Ennis
EBF
$560M
$543K 0.01%
31,154
+24,955
+403% +$438K
UVE icon
1593
Universal Insurance Holdings
UVE
$1.19B
$543K 0.01%
39,230
+26,349
+205% +$465K
EOG icon
1594
EOG Resources
EOG
$75.2B
$542K 0.01%
15,071
-20,977
-58% -$941K
LMAT icon
1595
LeMaitre Vascular
LMAT
$1.89B
$542K 0.01%
16,674
+13,737
+468% +$412K
HBB icon
1596
Hamilton Beach Brands
HBB
$445M
$541K 0.01%
27,818
+17,412
+167% +$299K
VSAT icon
1597
Viasat
VSAT
$11.6B
$541K 0.01%
15,743
-510
-3% -$19.3K
AMRX icon
1598
Amneal Pharmaceuticals
AMRX
$5.46B
$540K 0.01%
139,332
+104,203
+297% +$446K
NTUS
1599
DELISTED
Natus Medical Inc
NTUS
$539K 0.01%
31,471
+27,330
+660% +$517K
ALX
1600
Alexander's
ALX
$1.39B
$538K 0.01%
2,195
+1,559
+245% +$395K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.